Rinker-Schaeffer CW - Search Results

1

Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential.

Dubauskas Z, Beck TP, Chmura SJ, Kovar DA, Kadkhodaian MM, Shrivastav M, Chung T, Stadler WM, Rinker-Schaeffer CW. Dubauskas Z, et al. Clin Cancer Res. 1998 Oct;4(10):2391-8. Clin Cancer Res. 1998. PMID: 9796970

2

Identification of a novel metastasis-suppressor region on human chromosome 12.

Luu HH, Zagaja GP, Dubauskas Z, Chen SL, Smith RC, Watabe K, Ichikawa Y, Ichikawa T, Davis EM, Le Beau MM, Rinker-Schaeffer CW. Luu HH, et al. Cancer Res. 1998 Aug 15;58(16):3561-5. Cancer Res. 1998. PMID: 9721861

3

Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.

Chekmareva MA, Kadkhodaian MM, Hollowell CM, Kim H, Yoshida BA, Luu HH, Stadler WM, Rinker-Schaeffer CW. Chekmareva MA, et al. Cancer Res. 1998 Nov 1;58(21):4963-9. Cancer Res. 1998. PMID: 9810006

4

In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer.

Beck TP, Kirsh EJ, Chmura SJ, Kovar DA, Chung T, Rinker-Schaeffer CW, Stadler WM. Beck TP, et al. Urology. 1999 Sep;54(3):573-7. doi: 10.1016/s0090-4295(99)00210-1. Urology. 1999. PMID: 10475376

5

Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.

Yoshida BA, Dubauskas Z, Chekmareva MA, Christiano TR, Stadler WM, Rinker-Schaeffer CW. Yoshida BA, et al. Cancer Res. 1999 Nov 1;59(21):5483-7. Cancer Res. 1999. PMID: 10554023

6

Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.

Kim HL, Vander Griend DJ, Yang X, Benson DA, Dubauskas Z, Yoshida BA, Chekmareva MA, Ichikawa Y, Sokoloff MH, Zhan P, Karrison T, Lin A, Stadler WM, Ichikawa T, Rubin MA, Rinker-Schaeffer CW. Kim HL, et al. Cancer Res. 2001 Apr 1;61(7):2833-7. Cancer Res. 2001. PMID: 11306453

7

In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.

Chien M, Astumian M, Liebowitz D, Rinker-Schaeffer C, Stadler WM. Chien M, et al. Cancer Chemother Pharmacol. 1999;44(1):81-7. doi: 10.1007/s002800050948. Cancer Chemother Pharmacol. 1999. PMID: 10367753

8

A G2/M growth arrest response to low-dose intermittent H2O2 in normal uroepithelial cells.

Chien M, Rinker-Schaeffer C, Stadler WM. Chien M, et al. Int J Oncol. 2000 Sep;17(3):425-32. doi: 10.3892/ijo.17.3.425. Int J Oncol. 2000. PMID: 10938379

9

Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cells.

Berger JC, Vander Griend D, Stadler WM, Rinker-Schaeffer C. Berger JC, et al. Anticancer Drugs. 2004 Jul;15(6):559-68. doi: 10.1097/01.cad.0000132233.36512.fa. Anticancer Drugs. 2004. PMID: 15205597 Review.

10

Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.

Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW. Kauffman EC, et al. J Urol. 2003 Mar;169(3):1122-33. doi: 10.1097/01.ju.0000051580.89109.4b. J Urol. 2003. PMID: 12576866 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters